Grupo Angeles Files SC 13D for Auna S.A.

TL;DR

**Grupo Angeles just filed a 13D on Auna S.A. – ownership change incoming.**

AI Summary

Grupo Angeles Servicios de Salud, S.A. de C.V. has filed an SC 13D, indicating a change in beneficial ownership of Auna S.A. The filing, dated August 22, 2024, does not specify a dollar amount for the stake acquired but details the reporting person's address in Mexico City and their role within the Grupo Angeles conglomerate. This filing is an amendment to a previous filing.

Why It Matters

This filing signals a significant shift in the ownership structure of Auna S.A., potentially impacting its strategic direction and market position. Investors will be watching for further disclosures regarding the extent of Grupo Angeles's influence.

Risk Assessment

Risk Level: medium — SC 13D filings often precede significant corporate actions or shifts in control, which can introduce volatility and uncertainty for investors.

Key Players & Entities

• Grupo Angeles Servicios de Salud, S.A. de C.V. (company) — Reporting Person
• Auna S.A. (company) — Subject Company
• CORPVAZA, S.A. DE C.V. (company) — Group Member
• GRUPO EMPRESARIAL ANGELES, S.A. DE C.V. (company) — Group Member
• MR. OLEGARIO VAZQUEZ ALDIR (person) — Group Member

FAQ

Key Financial Figures

• $0.01 — lass A Ordinary Shares, nominal value US$0.01 per share (Title of Class of Securiti

Filing Documents

• gass_sch13d-082224.htm (SC 13D) — 62KB
• ex-1.htm (EX-1) — 7KB
• 0001999371-24-010550.txt ( ) — 71KB

SECURITY AND ISSUER

ITEM 1. SECURITY AND ISSUER This statement on Schedule 13D relates to the Class A Ordinary Shares, nominal value US$0.01 per share (the " Ordinary Shares "), of Auna S.A., a public limited liability company incorporated in Grand Duchy of Luxembourg (" Auna ", or the " Issuer "). The principal executive offices of the Issuer are located at: 46A, Avenue J.F. Kennedy, L-1855 Luxembourg, Grand Duchy of Luxembourg.

IDENTITY AND BACKGROUND

ITEM 2. IDENTITY AND BACKGROUND (a) This Schedule 13D is being filed by: i. Grupo Ángeles Servicios de Salud, S.A. de C.V. (" GASS "); ii. Grupo Empresarial Ángeles, S.A. de C.V. (" GEA "); iii. Corpvaza, S.A. de C.V. (" Corpvaza "); and iv. Mr. Olegario Vázquez Aldir (" Mr. Vázquez Aldir "). GASS, GEA, Corpvaza and Mr. Vázquez Aldir are collectively referred to as the " Reporting Persons ." Mr. Vázquez Aldir directly controls Corpvaza, which controls GEA, which is the parent company of GASS, the direct holder of the securities of the Issuer. (b) The address of the principal business office of the Reporting Persons is Camino a Santa Teresa 1055, piso 14, Héroes de Padierna, La Magdalena Contreras, Mexico, 10700. (c) The principal business of GASS is the operation and management of private hospitals within Mexico. GEA is the parent company of GASS and its principal business is to own investments in private hospitals in Mexico, through GASS, as well as investments in the communications, tourism and financial sectors within Mexico. Corpvaza's principal business is to own its investment in GEA. The principal occupation of Mr. Vázquez Aldir is being the chief executive officer of GEA. (d) During the last five years, none of the Reporting Persons has been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors). (e) During the last five years, none of the Reporting Persons was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) The Reporting Persons are citizens or incorporated under the laws of the United Mexican States.

SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION The Ordinary Shares covered by this Schedule 13D were acquired by GASS at various times in 2024. GASS used available cash on hand to acquire the Ordinary Shares.

PURPOSE OF TRANSACTION

ITEM 4. PURPOSE OF TRANSACTION The Reporting Persons have acquired securities described in this Schedule 13D for strategic investment purposes. The Reporting Persons expect to continuously review and evaluate the Issuer's financial condition and prospects and their interest in, and intentions with respect to, the Issuer and their investment in the securities of the Issuer, and depending on: market, economic, and industry conditions, their continuing evaluation of the business, strategies, prospects, management, governance, operations, performance, financial matters, capital structure, market positions, strategic and other transactions of the Issuer, alternative investment opportunities and changes in law and/or regulations, and all other factors that may be deemed relevant, including but not limited to the Issuer's business and financial condition, and results of operations; the relative attractiveness of other business and investment opportunities; and other future developments; the Reporting Persons may dispose of or acquire additional securities of the Issuer. CUSIP No. L0415A 103 Page 7 of 9 The Reporting Persons may engage in constructive discussions with the Issuer's management and/or board of directors (the " Board "), other shareholders of the Issuer and other interested parties that may relate to the business, management, operations (including cost structure), assets, capitalization, financial condition, strategic plans, governance, Board composition, and the future of the Issuer. in the Issuer through various transactions, including, without limitation, derivative transactions or a pledge of their interests in the securities of the Issuer as collateral for liquidity purposes. The Reporting Persons do not have any current plans or proposals which relate to or would result in any of the actions described in Ite

INTEREST IN SECURITIES OF AUNA S.A

ITEM 5. INTEREST IN SECURITIES OF AUNA S.A. (a), (b) The following disclosure assumes there are 30,000,000 Ordinary Shares outstanding as of March 21, 2024, as reported in the prospectus dated March 21, 2024 filed by the Issuer with the Securities and Exchange Commission on March 25, 2024 pursuant to the Final Prospectus. Pursuant to Rule 13d-3 under the Act, the Reporting Persons may be deemed to beneficially own 6,138,989 shares of Ordinary Shares, which constitutes approximately 20.46% of the outstanding Ordinary Shares. (c) Except as set forth in this Schedule 13D, none of the Reporting Persons nor, to the best knowledge of the Reporting Persons, without independent verification, any person named in Item 2 hereof has effected any transaction in the Ordinary Shares during the past 60 days. (d) To the best knowledge of the Reporting Persons, no person other than the Reporting Persons has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities beneficially owned by the Reporting Persons identified in this Item 5. (e) Not applicable

CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS

ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF AUNA S.A. Except as described above, to the knowledge of the Reporting Persons, there are no contracts, arrangements, understandings or relationships (legal or otherwise), including, but not limited to, the transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies, among the persons named in Item 2 or between such persons and any other person, with respect to any securities of Issuer, including, but not limited to, any securities pledged or otherwise subject to a contingency the occurrence of which would give another person voting power or investment power over such securities.

MATERIAL TO BE FILED AS EXHIBITS

ITEM 7. MATERIAL TO BE FILED AS EXHIBITS Exhibit 1 . Agreement of Joint Filing by GASS, GEA, Corpvaza and Mr. Vázquez Aldir executed on August 22, 2024. CUSIP No. L0415A 103 Page 8 of 9 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this Schedule 13D is true, complete, and correct. Dated as of August 22, 2024 Grupo Angeles Servicios de Salud, S.A. de C.V. /s/ Jose Luis Alberdi Gonzalez Name: Jose Luis Alberdi Gonzalez Title: Legal Vice President Grupo Empresarial Angeles, S.A. de C.V. /s/ Jose Luis Alberdi Gonzalez Name: Jose Luis Alberdi Gonzalez Title: Legal Vice President Corpvaza S.A. de C.V. /s/ Jose Luis Alberdi Gonzalez Name: Jose Luis Alberdi Gonzalez Title: Legal Vice President Olegario Vázquez Aldir /s/ Jose Luis Alberdi Gonzalez Name: Jose Luis Alberdi Gonzalez (5) Title: Authorized Signatory (5) Jose Luis Alberdi Gonzalez is signing on behalf of Mr. Vázquez Aldir pursuant to a power of attorney dated April 12, 2024, which was previously filed with the Commission as an exhibit to a Schedule 13G filed by Mr. Vázquez Aldir on April 12, 2024 (SEC File No. 005-94489).

View Full Filing

View this SC 13D filing on SEC EDGAR